Article info
PDFOriginal article
Validation of RP-HPLC method to assess the compatibility of metoclopramide and midazolam intravenous mixture used in patients with cancer
- Correspondence to Dr Carla Masini, Oncology Pharmacy Unit, Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori (IRST) IRCCS, Forlì 47014, Italy; carla.masini{at}irst.emr.it
Citation
Validation of RP-HPLC method to assess the compatibility of metoclopramide and midazolam intravenous mixture used in patients with cancer
Publication history
- Received February 23, 2018
- Revised April 25, 2018
- Accepted May 1, 2018
- First published May 15, 2018.
Online issue publication
October 24, 2019
Article Versions
- Previous version (15 May 2018).
- You are viewing the most recent version of this article.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
© European Association of Hospital Pharmacists 2019. No commercial re-use. See rights and permissions. Published by BMJ.